EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.45 Cr | ₹5.55 Cr | ₹5.00 Cr | ₹4.91 Cr | ₹5.24 Cr |
What is the latest Contingent Liabilities ratio of EVEREST ORGANICS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹4.45 Cr |
| Mar2025 | ₹5.55 Cr |
| Mar2024 | ₹5.00 Cr |
| Mar2023 | ₹4.91 Cr |
| Mar2022 | ₹5.24 Cr |
How is Contingent Liabilities of EVEREST ORGANICS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.45 Cr | -19.77 | |
| Mar2025 | ₹5.55 Cr | 10.90 | |
| Mar2024 | ₹5.00 Cr | 1.83 | |
| Mar2023 | ₹4.91 Cr | -6.35 | |
| Mar2022 | ₹5.24 Cr | - | |
Compare Contingent Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹241.3 Cr | 0.9% | 7.2% | -39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 0.9% |
7.2% |
-39.2% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses